An accomplished entrepreneur-advisor and innovative tactician, New York resident Richard DiVenuto has served as a consultant to multiple organizations in the finance, biotechnology, and nutraceutical sectors across states and cities including Boston, Massachusetts, Florida, and California. Richard DiVenuto supports research into allogeneic Chimeric Antigen Receptor (CAR) T cells, which can involve the use of virus-specific memory T cells. T cells helping the body fight infection. Memory T cells develop in response to specific foreign substances and remain in the body after healing. These cells can differentiate into multiple effector T cells when the body gets re-exposed to an infection. Effector T cells attack the foreign invaders. Due to these special functionalities, T cells are an important focus of multiple vaccines and cancer therapy research avenues. Here are three common subtypes of T cells: Naive T cells: Occurring in continuous circulation between the blood and secondary lymphoid organs, Naive T cells feature unique surface proteins that respond to various external signals, including those from foreign invaders. Central memory T cells: While these cells have a high capacity to self-renew, they change over to effector cells poorly. Effector memory T cells: Found in non-lymphoid peripheral tissues, such as the lung and liver, effector memory T cells play an important role in fighting viral, bacterial, and parasitic infections.